“Abbott Laboratories will soon acquire the biggest share of India’s pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd.,” the Wall Street Journal reports in an article that examines how pharmaceutical companies are tapping into emerging markets as a way to bolster sales.
Private Sector Involvement
“A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available,” suggest the authors of a study published online Monday in the journal Pedatrics, Reuters reports (Joelving, 8/23).
Also In Global Health News: IDUs In Kenya; Haiti Recovery; Pandemic Preparedness; Somalia Hunger; HIV In Mozambique; Strengthening Immune System Against HIV
Kenya Drafts Policy To Address HIV In IDUs In Kenya, “[i]ntravenous drug users (IDUs) have been largely ignored by the government’s HIV programmes on the basis that drug-taking is illegal, but a new policy is being drafted with the aim of reducing HIV transmission among this high-risk group,” IRIN/PlusNews reports.…
The Associated Press reports on a recent effort to use text messages to track the authenticity of antimalarials in Africa, where “more than 30 percent of malaria medicines are estimated to be fake.”
Also In Global Health News: Ebola Drug Study; Niger Hunger Crisis; WHO’s Breastfeeding Guidelines For HIV-Positive Mothers; Slowing India’s Birth Rate; Food Aid In Somalia; Transaction Tax
Treatment Administered To Monkeys Within Hour OfÂ Ebola InfectionÂ Found To Be 60%Â Effective, Study FindsÂ “A treatment administered to rhesus monkeys within an hour of being infected by the deadliest strain of Ebola was 60 percent effective, and a companion drug was 100-percent effective in shielding cynomolgus monkeys against Ebola’s cousin, the…
“Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, [U.S.] federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public-health emergencies,” Tribune Company/Seattle Times reports. “The overhaul includes manufacturing refinements aimed at shaving weeks off the time it takes to produce pandemic flu vaccine and a series of steps aimed at more quickly detecting promising scientific discoveries and getting them to market,” the news service writes (Zajac, 8/19).
Blog: U.S. Humanitarian Assistance Remains A ‘Sound Investment’ In view of World Humanitarian Day, a Huffington PostÂ blog discusses the “lessons” of disaster responseÂ and the global “proliferation of humanitarian crises.” First, the authors write that “the number of people affected by disasters is on the rise,” mostly due to conflict and…
Global vaccine sales “grew by a healthy 16 percent last year, when sales shot up to $22.1 billion, healthcare market research publisher Kalorama Information reported Friday,” according to Associated Press. Kalorama is also forecasting sales “will rise at a compound annual rate of 9.7 percent during the next five years,” (Johnson, 8/14).
Lancet Examines Health Workers Lost To International Organizations A Lancet Comment discusses how developing country doctors and nurses who are recruited by in-countryÂ international organizations, research institutions and non-governmental organizations (NGOs) can “prevent government-trained doctors and nurses from contributing to their [national health service] NHS.” The authors write that some of…
“Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year’s worth of AIDS medicines â€¦ in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world,” Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.